![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1254 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Timmers, Jan (Tecan 2006– Senior VP Sales Value Added Reseller Business joined Tecan US 1992) | Sales Manager / Marketing Manager | Tecan (Group) | Zürich (region) |
| Tintrup, Hartmut (Cellbox Solutions 202311– CEO before Lonza Cologne + Cevec + amaxa US + Exelixis) | Chief Executive Officer (CEO) | Cellbox Solutions (Group) | Schleswig-Holstein (federal state) |
| Tolcher, Anthony (NEXT-Oncology 201811 CEO + Founder before START (South Texas Accelerated Research Therapeutics)) | Advisory Board member | Boehringer Ingelheim (Group) | Northwestern Switzerland (region) |
| Tolnay, Markus (Univ Basel 201704 Manager of Institute of Medical Genetics and Pathology at Univ Hospital Basel) | President/Director/Head of Research Organisation/Unit | University of Basel | Northwestern Switzerland (region) |
| Tomsicek, Michael (CRISPR Therapeutics 201711– CFO before Abiomed + Cubist + GE Healthcare) | Chief Financial Officer (CFO) | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Topen, Andrew (EuropaBio 202009– Chairman main org Novartis before Pfizer + GSK) | Board member (all kinds of boards: supervisory, advisory, management etc.) | EuropaBio aisbl – the European Association of Bioindustries | Brussels (region) |
| Torres Hubiche, Félix (NexMR 202307 CEO + Co-Founder) | Chief Executive Officer (CEO) | NexMR GmbH | Zürich (region) |
| Torti, Frank (Roivant 201808 Vant Investment Chair before New Enterprise Associate 2007–2018) | Investment Manager | Roivant (Group) | Northwestern Switzerland (region) |
| Tóth von Kiskér, Thomas A. (Zeria 202005 CEO of Tillotts Pharma AG) | Chief Executive Officer (CEO) | Zeria (Group) | Switzerland_other |
| Traeger, Stefan (Tecan 201307–201706 Head of Life Sciences before Leica Microsystems + Zeiss LEAVES 2017) | Board member, executive | Tecan (Group) | Zürich (region) |
| Tregay, Steven (Forma Therapeutics 200810–201903 CEO + founder before Novartis Venture Funds Managing Director) | Chief Executive Officer (CEO) | Forma Therapeutics (Group) | Massachusetts (federal state) |
| Tripet, Jean-Philippe (Aravis 200205 Managing Director + Board of Directors ESBATech) | Managing Partner (investment firm) | Aravis (Group) | Zürich (region) |
| Trüeb, Hans Rudolf (Walder Wyss 202009 Senior Partner + Dinaqor 202009– General Counsel + Corporate Secretary) | Attorney / Lawyer | Walder Wyss AG | Zürich (region) |
| Tsai, John (Novartis 201908 Head Global Drug Development + CMO) | Research & Development Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Tschudin, Marie-France (Novartis 201906– President Novartis Pharmaceuticals joined 2017 before 10y at Celgene) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Northwestern Switzerland (region) |
| Tsybin, Yuri (Spectroswiss 202211 CEO + Founder before EPFL 201005 Professor) | Professor | Spectroswiss (Group) | Région Lémanique (region) |
| Tulstrup, Søren (Hansa Biopharma 2018– CEO formerly Galenica + Shire + Santaris Pharma) | Chief Executive Officer (CEO) | Hansa Biopharma AB | Skåne |
| Tur, Christelle (Debiopharm 201504 Communications Coordinator) | Public Relations Manager / Investor Relations Manager | Debiopharm (Group) | Région Lémanique (region) |
| Udier-Blagovic, Marina (Nouscom 202002– CEO joined 201609 as COO before Versant Ventures + Novartis + McKinsey) | Chief Operating Officer (COO) | Nouscom (Group) | Northwestern Switzerland (region) |
| Umaña, Pablo (GlycaArt 200810 CSO and Co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Roche (Group) | Zürich (region) |
| Urech, David (Numab 201910 CEO + Co-Founder before Esbatech 2004–2010) | Chief Executive Officer (CEO) | Numab (Group) | Zürich (region) |
| Uteng, Marianne (Novartis 202010 Associate at Novartis Venture Fund) | n. a. | Novartis (Group) | Northwestern Switzerland (region) |
| Utiger, Lukas (Lonza 201208 COO of Lonza Bioscience STEPPED DOWN 2/13) | Chief Operating Officer (COO) | Lonza (Group) | Northwestern Switzerland (region) |
| Vachicouras, Nicolas (Neurosoft Bioelectronics 202103 CEO + Co-Founder) | Chief Executive Officer (CEO) | Neurosoft Bioelectronics (CH) | Région Lémanique (region) |
| Vahrson, Wolfgang (Genedata 200910 before Microdiscovery 200501) | n. a. | Genedata (Group) | Northwestern Switzerland (region) |
| Valdettaro, Sharon (Roche 201109 Roche Partnering) | Business Development Manager / Strategy Manager | Roche (Group) | Northwestern Switzerland (region) |
| Valinder, Kerstin (Nycomed 200808 Executive VP Business Developm) | Business Development Manager / Strategy Manager | Takeda (Group) | Zürich (region) |
| van Alphen, Frits (Inositec 201801–CMO before Roche + Vifor Pharma + Novartis) | Chief Medical Officer (CMO) | Vifor Pharma (Group) | Zürich (region) |
| van Berkel, Patrick (Celtic Therapeutics 201207– SVP RnD of ADC Therapeutics before Genmab + Crucell + Pharming) | Research & Development Manager | ADC Therapeutics (Group) | Région Lémanique (region) |
| van den Berg, Erik (Memo Therapeutics 202311– CEO before AM-Pharma 201109– CEO before VP Business Development) | Chief Executive Officer (CEO) | Memo Therapeutics AG (MTx) | Zürich (region) |
| Van den Berghe, Jan (Novalis Biotech 202205 Manaing Director + Co-Founder formerly Genohm 201503) | Managing Director | Agilent (Group) | Région Lémanique (region) |
| van den Oever, Jeroen (Sun Bioscience 202310 CFO) | Chief Executive Officer (CEO) | Région Lémanique (region) | |
| Van der Heide, Teun (Lonza 201303 Head Lonza Bioscience) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| van der Veen, Lars (iOnctura 201706– COO before Solvay Pharma + Organon + Boehringer Ingelheim) | Chief Operating Officer (COO) | iOnctura (Group) | Région Lémanique (region) |
| van Hagen, Paul (Xeltis 201602– CFO before Prosensa + Crucell + Ernst & Young) | Chief Financial Officer (CFO) | Xeltis (Group) | Zürich (region) |
| van Houten, François Adrianus (Frans) (Philips 201104– designated CEO before since 1986 at Philips) | Chief Executive Officer (CEO) | Philips (Group) | North Brabant (province, NL) |
| van Renterghem, Guillaume (LifeSci 202106 Managing Director at LifeSci Advisors in Zurich) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
| Vanderhaegen, Frederic (Tecan 201202 Head Life Sciences Business) | President/Director/Head Business Group/Unit/Division | Tecan (Group) | Zürich (region) |
| Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) | Board member, non-executive | Numab (Group) | Zürich (region) |
| Vatiska, Katrin (MTIP 202402 Investment Partner) | Partner (venture partner) | MTIP (Group) | Northwestern Switzerland (region) |
| Végh, Mátyás (Creoptix 201210–201912 Managing Partner before Genetics Company LEFT 1/20) | Managing Partner | Spectris (Group) | Zürich (region) |
| Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) | Chief Executive Officer (CEO) | Basilea (Group) | Northwestern Switzerland (region) |
| Velasco, Martin (AC Immune 201401 Board Chairman) | Board member, non-executive | AC Immune S.A. (Nasdaq: ACIU) | Région Lémanique (region) |
| Venturi, Miro (Novigenix 202211 Board Director) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Novigenix S.A. | Région Lémanique (region) |
| Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) | Chief Executive Officer (CEO) | Quercis Pharma (Group) | Central Switzerland (region) |
| Verbraeken, Paul (Evolva 201105 Investor Relations Manager) | Public Relations Manager / Investor Relations Manager | Lallemand (Group) | Northwestern Switzerland (region) |
| Verhoeven, Wouter (BioGeneration Ventures 202109– Venture Partner before NBE-Therapeutics + mAbxience) | Partner (venture partner) | BioGeneration Ventures B.V. (BGV) | North Holland (province, NL) |
| Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) | n. a. | ObsEva (Group) | Région Lémanique (region) |
| Vianna, Eduardo (NovaGo Therapeutics 202009– Chief Development Officer before CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NovaGo Therapeutics AG | Zürich (region) |
| Vicari, Alain (Calypso Biotech 201703 CEO) | Chief Executive Officer (CEO) | Novartis (Group) | Région Lémanique (region) |
| Vieira, Samantha (Anjarium Biosciences 202207– COO before Biogen + Nightstar Therapeutics) | Chief Operating Officer (COO) | Anjarium Biosciences AG | Zürich (region) |
| Vignon, Guillaume (BeiGene 201810 SVP Business Development at BeiGene Switzerland GmbH) | Business Development Manager / Strategy Manager | BeiGene (Group) | Northwestern Switzerland (region) |
| Vignot, Julien (Vifor Pharma 202111 Head of Investor Relations) | Public Relations Manager / Investor Relations Manager | Vifor Pharma (Group) | Zürich (region) |
| Virani, Shafique (Recursion 202009 Chief Corp Development Officer formerly Roche Global Head Neuroscience Partnering) | Business Development Manager / Strategy Manager | Recursion Pharmaceuticals (Group) | Utah (federal state) |
| Vogel, Bernard (Endeavour Vision 201409 Managing Partner + Co-founder) | Managing Partner (investment firm) | Endeavour Vision (Group) | Région Lémanique (region) |
| Vogt, Joachim (AbbvVie 201809– Director Search + Evaluation Intl before Roche + eADMET + Wilex) | Business Development Manager / Strategy Manager | AbbVie (Group) | Rheinland-Pfalz (federal state) |
| von Bonin, Arne (Actelion 201608– CSO of Vaxxilon before Affiris + Bayer HealthCare + Schering) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Idorsia (Group) | Northwestern Switzerland (region) |
| von Capeller, Gaudenz (Cellestia Biotech 201707– CFO Piqur Therapeutics 201507 CEO) | Chief Financial Officer (CFO) | Cellestia Biotech AG | Northwestern Switzerland (region) |
| von der Weid, Sandya (LifeSci Advisors 202101 before Debiopharm) | n. a. | LifeSci (Group) | New York (federal state) |
| von Halem, Carl (Xlife Sciences 202112– CFO before CommneX + SaEnergy Systems) | Chief Financial Officer (CFO) | Xlife Sciences AG (SIX: XLS) | Zürich (region) |
| von Leoprechting, Achim (Tecan 201904– CEO joined 201310 before PerkinElmer + Packard Bioscience) | Business Development Manager / Strategy Manager | Tecan (Group) | Zürich (region) |
| von Schulthess, Konstantin (CDR-Life 202204 CFO) | Chief Financial Officer (CFO) | CDR-Life AG | Zürich (region) |
| Vonder Mühll, Daniel (SystemsX.ch 201104 Managing Director) | Managing Director | SystemsX.ch project (CH, 2004) | Zürich (region) |
| Vonlanthen, Nadine (Basilea 201211 Licensing Manager, BusDev + Licensing) | Business Development Manager / Strategy Manager | Basilea (Group) | Northwestern Switzerland (region) |
| Vuagniaux, Gregoire (Debiopharm 201905 Director of Translational Science) | n. a. | Debiopharm (Group) | Région Lémanique (region) |
| Vujevic, Manuela (InSphero 201311 Head of Marketing Communications) | Sales Manager / Marketing Manager | InSphero (Group) | Zürich (region) |
| Vunder, Kadri (Aravis 201307– Partner in life science team before LSVenture) | Managing Partner (investment firm) | Aravis (Group) | Zürich (region) |
| Wacker, Michael (BioMedPartners 202007 before Polyneuron 201805– CBO before GlycoVaxyn CSO + Co-Founder) | Chief Business Officer (CBO) | BioMedPartners (Group) | Northwestern Switzerland (region) |
| Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) | Business Development Manager / Strategy Manager | SGS (Group) | Région Lémanique (region) |
| Waddington, Simon (Evolva 201707–201807 CEO before COO before Abunda Nutrition CEO RESIGNED 7/18) | Chief Executive Officer (CEO) | Lallemand (Group) | Northwestern Switzerland (region) |
| Wagner, Julian (Pevion Biotech 201110 Business Development) | Business Development Manager / Strategy Manager | Pevion Biotech AG | Espace Mittelland (region) |
| Wagner-Solbach, Volker (AMSilk 201704– Procurement + Supply Chain Manager before AVA-CO2 AG + Bayern Innovativ GmbH) | management (personnel) | AMSilk GmbH | Bayern (federal state) |
| Waldhoer, Maria (InterAx Biotech 201804 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | InterAx Biotech AG | Northwestern Switzerland (region) |
| Wales, Martin (UBS 200809 Analyst) | Analyst (Financial / Industry) | UBS (Group) | Switzerland_other |
| Walker, Adam (Informa 201307 Finance Director) | Chief Financial Officer (CFO) | Informa (Group) [NEW] | Central Switzerland (region) |
| Walker, Oliver (Evolva 201807–202202 CEO before CFO before Sivantos + Nobel Biocare + Sonova + Stratec) | Chief Executive Officer (CEO) | Lallemand (Group) | Northwestern Switzerland (region) |
| Wallnöfer, Andreas (Jeito Capital 202202– Partner Investor before BioMedPartners + Roche) | Partner (venture partner) | Jeito Capital (Group) | Île-de-France (region) |
| Walser, Charles (Tanovis 202101 CEO) | Chief Executive Officer (CEO) | Tanovis AG | Switzerland_other |
| Walther, Hansjörg (Solvias 2003–201402 CEO joined 1999 RETIRED 3/14) | Chief Executive Officer (CEO) | Solvias (Group) | Northwestern Switzerland (region) |
| Wanderer, Gaby (Xiril 201204 Product Manager) | Product Manager (personnel) | Tecan (Group) | Zürich (region) |
| Wanner, Antonia (Nestlé 202012 Head ESG Strategy + Deployment Unit) | President/Director/Head Business Group/Unit/Division | Nestlé (Group) | Région Lémanique (region) |
| Ward, Constance (Lonza 201610 Head External Communications) | Public Relations Manager / Investor Relations Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Warnack, Boris (BioDGraft 202209 CEO + Co-Founder before Holistick Medical + Xeltis) | Chief Executive Officer (CEO) | BioDGraft GmbH | Wien (state) |
| Watons, John A. (SomPharmaceuticals SA 201411 CEO) | Chief Executive Officer (CEO) | Amryt Pharma (Group) | Région Lémanique (region) |
| Watts, Michael (Hologic 202101 Investor Relations) | Public Relations Manager / Investor Relations Manager | Hologic (Group) | Massachusetts (federal state) |
| Wax, Martin B. (Alcon 200601 VP RnD + head Ophtalmology Discovery Research) | Research & Development Manager | Novartis (Group) | Central Switzerland (region) |
| Waxman, Allen (Roivant Sciences 201709– General Counsel before Eisai Inc + Kaye Scholer + Pfizer 2003–200803) | General Counsel / Chief Legal Officer (CLO) | Roivant (Group) | Northwestern Switzerland (region) |
| Weber, Dirk (Cellestia Biotech 201801 CMO) | Chief Medical Officer (CMO) | Cellestia Biotech AG | Northwestern Switzerland (region) |
| Weber, Frank (Polyphor 201901– CMDO before InterMune EU + Merck Serono + American Cyanamid/Lederle + Synthelabo + Merck) | Chief Medical Officer (CMO) | Spexis (Group) | Northwestern Switzerland (region) |
| Weber, Tim O. (Parter Capital 201411 Board Chairman) | Board member, executive | Parter Capital Group AG | Switzerland_other |
| Wehren, Achim (Tecan 200407 Marketing Manager Biopharma) | n. a. | Tecan (Group) | Zürich (region) |
| Weikert, Gunnar (Inventages Venture Capital 201609 Founder) | Company Founder | Inventages Venture Capital Investments Inc. | Région Lémanique (region) |
| Weiler, Andreas (Lonza 201505 Head of Emerging Technology, Lonza Pharma&Biotech) | n. a. | Lonza (Group) | Northwestern Switzerland (region) |
| Weinstein, Jack (Relief Therapeutics 202010– CFO before Avalon Group + Catalyst Pharmaceuticals + Sterlington Group) | Chief Financial Officer (CFO) | Relief Therapeutics (Group) | Région Lémanique (region) |
| Weiss, Andrew C. (Idorsia 201706– SVP + Head Investor Relations + Corporate Communications before Actelion) | Public Relations Manager / Investor Relations Manager | Idorsia (Group) | Northwestern Switzerland (region) |
| Wellauer, Thomas (Novartis 200702 Head Corporate Service) | n. a. | Novartis (Group) | Northwestern Switzerland (region) |
| Welten, Harry (Cytos Biotechnology 201203 CFO) | Chief Financial Officer (CFO) | Kuros (Group) | Zürich (region) |
| Wenzel, Ryan (CovalX 201006 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | CovalX (Group) | Zürich (region) |
| Werder, Claudio | n. a. | Vontobel (Group) | Zürich (region) |
| Werk, Tobias (Bionter 202204 CEO + Founder) | Chief Executive Officer (CEO) | Bionter AG | Northwestern Switzerland (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
